These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 24119851)

  • 1. Race and the insulin resistance syndrome.
    Kramer H; Dugas L; Rosas SE
    Semin Nephrol; 2013 Sep; 33(5):457-67. PubMed ID: 24119851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents.
    van der Heijden GJ; Wang ZJ; Chu ZD; Sauer PJ; Haymond MW; Rodriguez LM; Sunehag AL
    Obesity (Silver Spring); 2010 Feb; 18(2):384-90. PubMed ID: 19696755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
    Gallagher EJ; Leroith D; Karnieli E
    Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers.
    Lee S; Bacha F; Gungor N; Arslanian S
    J Pediatr; 2008 Feb; 152(2):177-84. PubMed ID: 18206686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.
    de Larrañaga G; Wingeyer SP; Graffigna M; Belli S; Bendezú K; Alvarez S; Levalle O; Fainboim H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):319-24. PubMed ID: 18160600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification.
    Cruz ML; Shaibi GQ; Weigensberg MJ; Spruijt-Metz D; Ball GD; Goran MI
    Annu Rev Nutr; 2005; 25():435-68. PubMed ID: 16011474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
    J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome.
    Socha P; Wierzbicka A; Neuhoff-Murawska J; Włodarek D; Podleśny J; Socha J
    Rocz Panstw Zakl Hig; 2007; 58(1):129-37. PubMed ID: 17711101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance (metabolic) syndrome in children.
    Rosenberg B; Moran A; Sinaiko AR
    Panminerva Med; 2005 Dec; 47(4):229-44. PubMed ID: 16489322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM; McCullough AJ
    Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.
    Willner IR; Waters B; Patil SR; Reuben A; Morelli J; Riely CA
    Am J Gastroenterol; 2001 Oct; 96(10):2957-61. PubMed ID: 11693332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GI epidemiology: nonalcoholic fatty liver disease.
    Angulo P
    Aliment Pharmacol Ther; 2007 Apr; 25(8):883-9. PubMed ID: 17402991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classifying Africans with the metabolic syndrome.
    Schutte AE; Schutte R; Huisman HW; Rooyen JM; Malan L; Olckers A; Malan NT
    Horm Metab Res; 2009 Feb; 41(2):79-85. PubMed ID: 19105119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of diagnostic criteria of the metabolic syndrome in 3 ethnic groups of Canada.
    Chateau-Degat ML; Dewailly E; Poirier P; Gingras S; Egeland GM
    Metabolism; 2008 Nov; 57(11):1526-32. PubMed ID: 18940389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
    Khan SH; Khan FA; Ijaz A; Sattar A; Dilawar M; Hashim R
    J Ayub Med Coll Abbottabad; 2008; 20(3):17-22. PubMed ID: 19610507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and renal failure: similarities and differences.
    Kaysen GA
    Panminerva Med; 2006 Sep; 48(3):151-64. PubMed ID: 17122751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.